Array BioPharma, Inc. (ARRY)
|
3.77
-0.08 (-2.08%)
|
|
|
|
ARRY additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ARRY Profile
•
Exchange
NASDAQ
•
Top Holders (By Fund)
•
Competitors
•
Executives
Mr. Kyle A. Lefkoff M.B.A.
Exec. Chairman
Mr. Ron Squarer BSc (Biochemistry) A
45
Chief Exec. Officer and Director
Dr. Kevin Koch Ph.D.
Co-Founder
Pres Chief Scientific Officer and Director
Mr. David L. Snitman Ph.D.
Co-Founder
Chief Operating Officer VP of Bus. Devel. and Director
Mr. R. Michael Carruthers
Chief Financial Officer and Principal Accounting Officer
Exec. Chairman
Mr. Ron Squarer BSc (Biochemistry) A
45
Chief Exec. Officer and Director
Dr. Kevin Koch Ph.D.
Co-Founder
Pres Chief Scientific Officer and Director
Mr. David L. Snitman Ph.D.
Co-Founder
Chief Operating Officer VP of Bus. Devel. and Director
Mr. R. Michael Carruthers
Chief Financial Officer and Principal Accounting Officer
•
Employee Count
250
Special Offers
Competitors
ARRY earnings
Date
Actual
Expected
Prev Yr Qtr
8/13/2012
-0.09
-0.13
-0.17
4/30/2012
-0.11
-0.16
-0.20
1/30/2012
-0.06
-0.12
-0.23
